Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019025519) A VACCINE COMPRISING A PCV2 ORF2 PROTEIN OF GENOTYPE 2B
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/025519 International Application No.: PCT/EP2018/070955
Publication Date: 07.02.2019 International Filing Date: 02.08.2018
IPC:
A61K 39/12 (2006.01) ,C07K 14/005 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
12
Viral antigens
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005
from viruses
01
DNA viruses
03
Herpetoviridae, e.g. pseudorabies virus
05
Epstein-Barr virus
Applicants:
INTERVET INTERNATIONAL B.V. [NL/NL]; Wim de Körverstraat 35 5831 AN Boxmeer, NL (AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BE, BF, BG, BH, BJ, BN, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CL, CM, CN, CO, CR, CU, CY, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GT, GW, HN, HR, HU, ID, IE, IL, IN, IR, IS, IT, JO, JP, KE, KG, KH, KM, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MC, MD, ME, MG, MK, ML, MN, MR, MT, MW, MX, MY, MZ, NA, NE, NG, NI, NL, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SI, SK, SL, SM, SN, ST, SV, SY, SZ, TD, TG, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, ZA, ZM, ZW)
INTERVET INC. [US/US]; 2 Giralda Farms Madison, NJ New Jersey 07940, US (US)
Inventors:
SNO, Melanie; NL
COX, Erik; NL
SEGERS, Ruud, Philip, Antoon, Maria; NL
Agent:
INTERVET INTERNATIONAL BV ASS. NO. 666; Wim de Körverstraat 35 5831 AN Boxmeer, NL
Priority Data:
17184630.603.08.2017EP
Title (EN) A VACCINE COMPRISING A PCV2 ORF2 PROTEIN OF GENOTYPE 2B
(FR) VACCIN COMPRENANT UNE PROTÉINE ORF2 DU PCV2 DE GÉNOTYPE 2B
Abstract:
(EN) The present invention pertains to a vaccine comprising an ORF2 encoded protein of porcine circo virus 2 (PCV2) and a pharmaceutically acceptable carrier, for use in a method to protect a pig against an infection with porcine circo virus type 2 by administering the vaccine to the pig, wherein the vaccine comprises less than 20 µg per dose of the ORF2 encoded protein, the protein being of a porcine circo virus of genotype 2b.
(FR) La présente invention concerne un vaccin comprenant une protéine codée par l’ORF2 du circovirus porcin de type 2 (PCV2) et un support pharmaceutiquement acceptable, destiné à être utilisé dans un procédé pour protéger un porc contre une infection par le circovirus porcin de type 2 par administration du vaccin au porc, le vaccin comprenant moins de 20 µg par dose de la protéine codée par l’ORF2, la protéine étant d'un circovirus porcin de génotype 2b.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)